Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Trading Down 2.5% – Time to Sell?

Posted by Bonnie Powley on May 17th, 2026

Shares of Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) dropped 2.5% during trading on Friday . The company traded as low as $28.96 and last traded at $29.00. Approximately 18,389 shares were traded during trading, a decline of 42% from the average daily volume of 31,436 shares. The stock had previously closed at $29.75.

Invesco Nasdaq Biotechnology ETF Stock Down 2.5%

The firm has a market capitalization of $65.54 million, a PE ratio of 17.03 and a beta of 0.62. The stock’s fifty day simple moving average is $29.14 and its 200 day simple moving average is $28.79.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 27th. Shareholders of record on Monday, March 23rd were issued a dividend of $0.0361 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend was Monday, March 23rd.

Institutional Trading of Invesco Nasdaq Biotechnology ETF

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in IBBQ. Ascentis Independent Advisors purchased a new stake in Invesco Nasdaq Biotechnology ETF during the first quarter valued at approximately $31,000. Royal Bank of Canada purchased a new stake in Invesco Nasdaq Biotechnology ETF during the fourth quarter valued at approximately $37,000. International Assets Investment Management LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the fourth quarter valued at approximately $41,000. MMA Asset Management LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the third quarter valued at approximately $51,000. Finally, Advisory Services Network LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the third quarter valued at approximately $52,000.

About Invesco Nasdaq Biotechnology ETF

(Get Free Report)

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.